Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Advanced Oxygen Technologies (AOXY) EBITDA (2016 - 2026)

Advanced Oxygen Technologies filings provide 17 years of EBITDA readings, the most recent being -$17348.0 for Q1 2026.

  • On a quarterly basis, EBITDA fell 155.73% to -$17348.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $45612.0, a 449.67% increase, with the full-year FY2025 number at $73677.0, up 933.26% from a year prior.
  • EBITDA hit -$17348.0 in Q1 2026 for Advanced Oxygen Technologies, down from $3204.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $62564.0 in Q2 2025 to a low of -$46286.0 in Q4 2024.
  • Median EBITDA over the past 5 years was -$2808.0 (2025), compared with a mean of $1762.5.
  • Biggest five-year swings in EBITDA: tumbled 380.0% in 2022 and later skyrocketed 2322.52% in 2025.
  • Advanced Oxygen Technologies' EBITDA stood at $53268.0 in 2022, then plummeted by 32.13% to $36155.0 in 2023, then plummeted by 228.02% to -$46286.0 in 2024, then skyrocketed by 106.92% to $3204.0 in 2025, then tumbled by 641.45% to -$17348.0 in 2026.
  • The last three reported values for EBITDA were -$17348.0 (Q1 2026), $3204.0 (Q4 2025), and -$2808.0 (Q3 2025) per Business Quant data.